home / stock / imlff / imlff quote
Last: | $4.96 |
---|---|
Change Percent: | -25.41% |
Open: | $5.4 |
Close: | $4.96 |
High: | $6.14 |
Low: | $4.87 |
Volume: | 42,042 |
Last Trade Date Time: | 11/10/2020 04:55:18 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.96 | $5.4 | $4.96 | $6.14 | $4.87 | 42,042 | 11-10-2020 |
$6.65 | $7.89 | $6.65 | $8.94 | $6.65 | 62,362 | 11-09-2020 |
$6.8449 | $4.9919 | $6.8449 | $6.88 | $4.68 | 52,470 | 11-06-2020 |
$4.98 | $4.764 | $4.98 | $5.48 | $4.67 | 30,966 | 11-05-2020 |
$4.671 | $5.05 | $4.671 | $5.5 | $4.432 | 49,899 | 11-04-2020 |
$5.2959 | $3.9627 | $5.2959 | $5.3744 | $3.95 | 58,488 | 11-03-2020 |
$3.7645 | $3.42778 | $3.7645 | $3.7645 | $3.4278 | 18,593 | 11-02-2020 |
$3.3373 | $3.37 | $3.3373 | $3.4421 | $3.33 | 7,837 | 10-30-2020 |
$3.32 | $3.4807 | $3.32 | $3.4881 | $3.27 | 12,691 | 10-29-2020 |
$3.32 | $3.5874 | $3.32 | $3.6083 | $3.32 | 21,463 | 10-28-2020 |
$3.61 | $3.3082 | $3.61 | $3.62 | $3.3 | 13,530 | 10-27-2020 |
$3.3994 | $3.2742 | $3.3994 | $3.3994 | $3.25 | 5,190 | 10-26-2020 |
$3.37 | $3.4 | $3.37 | $3.4 | $3.3 | 2,234 | 10-23-2020 |
$3.3901 | $3.5464 | $3.3901 | $3.59 | $3.35 | 9,076 | 10-22-2020 |
$3.51 | $3.55 | $3.51 | $3.5532 | $3.44 | 5,934 | 10-21-2020 |
$3.5 | $3.6138 | $3.5 | $3.62 | $3.4898 | 2,894 | 10-20-2020 |
$3.4 | $3.58 | $3.4 | $3.58 | $3.4 | 2,462 | 10-19-2020 |
$3.4901 | $3.45167 | $3.4901 | $3.522 | $3.4 | 3,287 | 10-16-2020 |
$3.471 | $3.75 | $3.471 | $3.75 | $3.04 | 11,187 | 10-15-2020 |
$3.755 | $3.8164 | $3.755 | $3.8164 | $3.5812 | 6,499 | 10-14-2020 |
News, Short Squeeze, Breakout and More Instantly...
InMed Pharmaceuticals Inc. Company Name:
IMLFF Stock Symbol:
OTCMKTS Market:
InMed Announces Closing of US$4.5 Million Private Placement PR Newswire VANCOUVER, BC , Feb. 16 , 2021 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (Nasdaq: INM) (TSX: IN), a clinical-stage pharmaceutical company developing medicat...
InMed Pharmaceuticals Reports Second Quarter Fiscal 2021 Financial Results Canada NewsWire VANCOUVER, BC , Feb. 11, 2021 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ: INM) (TSX: IN), a clinical-stage pharmaceutical company develo...
InMed Pharmaceuticals to Report Second Quarter Fiscal 2021 Financial Results Canada NewsWire VANCOUVER, BC , Feb. 5, 2021 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ: INM) (TSX: IN), a clinical-stage pharmaceutical company developing...